Trial Profile
Efficacy and Safety of Alitretinoin in the Treatment of Severe Chronic Hand Eczema Refractory to Topical Therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Alitretinoin (Primary)
- Indications Eczema
- Focus Registrational; Therapeutic Use
- Acronyms HANDEL
- Sponsors Stiefel Laboratories
- 29 Sep 2014 New trial record